At the conclusion of this activity, participants will be able to:

  1. Understand the latest in brain tumor PET imaging and theranostics
  2. Appreciate key advantages of brain tumor PET imaging and radionuclide theranostics for personalized medicine
  3. Identify the reasons why neuro-theranostics lags behind other theranostics approaches for tumors elsewhere in the body.

 

Session date: 
03/19/2026 - 12:00pm to 1:00pm CDT
Location: 
University of Chicago
5758 S. Maryland Avenue
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Michael Veronesi, MD, PhD